<DOC>
	<DOCNO>NCT02758548</DOCNO>
	<brief_summary>The purpose study determine accuracy Novel point care test ( POCT ) total IgE assay atopic patient . 120 patient atopic condition approximately 40 healthy subject enrol . Fingerstick capillary blood sample collect tested POCT device . Venous sample collect send reference laboratory measurement serum total IgE use reference immunoassay method .</brief_summary>
	<brief_title>Determination Accuracy Measurement Total Immunoglobulin E Using Test Device Atopic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Inclusion criterion : atopic patient Subjects diagnose atopic condition Subjects legal guardian able give inform consent Other protocoldefined inclusion criterion may apply Exclusion criterion : atopic patient Subjects receive antiIgE antibody treatment Subjects elevate IgE level reason allergic condition Other protocoldefined exclusion criterion may apply Inclusion criterion : healthy subject Subjects able give inform consent participation study accord local requirement / law . Exclusion criterion : healthy subject Subjects receive antiIgE antibody treatment Subjects suspect confirmed clinical diagnosis atopic condition Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Total IgE measurement</keyword>
	<keyword>Novel Point-of-care test device</keyword>
	<keyword>atopic condition</keyword>
	<keyword>vitro diagnostic test</keyword>
</DOC>